PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer Robinson, MD, MPH
Johns Hopkins University
Study Chair - Rosie Mngqibisa, MBChB, MPH
Durban Adult HIV CRS
Study Chair - Susan E. Cohn, MD, MPH
Northwestern University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gaborone Prevention/treatment Trials Crs (12701)
Gaborone, Botswana
- Kenya Medical Research Institute/center for Disease Control (kemri/cdc) Crs (31460)
Kisumu, Kenya
- Durban Adult Hiv Crs (11201)
Durban, South Africa
- Univ. of Witwatersrand Crs (11101)
Johannesburg, South Africa
- Uz-Parirenyatwa Crs (30313)
Harare, Zimbabwe
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Nov 2015
- Primary completion
- 15 Jun 2017
- Completion
- 15 Jun 2017
- Last update posted
- 1 Jul 2019
- Registered enrollment
- 62
- Registry id
- NCT02412436
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.